Abstract:Introduction Negative symptoms (NS) are an important clinical characteristic of schizophrenia. In recent years, clinical research on NS has focused on their clinical heterogeneity. Based on two-factor analysis, it has been proposed to divide NS into abulia-apathy (AA) and expressive deficit (ED) domains. A number of studies have shown that these domains have different effects on the clinical features of schizophrenia, which suggests different pathophysiological mechanisms of their development. Neurobiological differences between AA and DE have been identified in neuroimaging and immunological studies but there is less research on the genetic background of NS. Objectives To search for an association between the rs1344706 polymorphism of the zinc finger protein gene (ZNF804A) and the AA and ED subdomains. The rs1344706 polymorphism is one of the best-supported risk variants for schizophrenia. The risk genotype AA has been shown to be associated with clinical presentations of the disease. Methods The study included 1116 (741 (66.3% women) patients with schizophrenia. The diagnosis was made according to ICD-10 criteria (item F20). The average age of the patients was 38.4 (13.6) years, age at disease onset was 26.1 (10.6) years. NS were assessed with the PANSS. The PANSS-derived AA domain consisted of Emotional withdrawal (PANSS item N2), Apathetic social withdrawal (N4), Active social avoidance (G16). The DE domain included Blunted affect (N1), Poor rapport (N3), Lack of spontaneity (N6), Mannerism and posturing (G5), Motor retardation (G7), Disturbance of volition (G13). Genotyping of the ZNF804A rs1344706 polymorphism was carried out using HRM-PCR. ANOVA with genotype and sex as independent variables, and age at the time of disease manifestation and its duration as covariates was used. Post hoc tests were performed using Bonferroni correction. Results A significant effect of the rs1344706 polymorphism on the severity of symptoms in the AA domain was revealed (F=5.88, df=2, p=0.002). In carriers of the CC genotype, the severity of symptoms was significantly lower than in carriers of the AA genotype and the AC genotype (8.4(3.5), 9.4(7.4) and 8.8(3.5) points, respectively). This effect was independent of sex and was not mediated by age at onset or duration of disease. There was no effect of the rs1344706 polymorphism on the severity of symptoms in the ED domain. Conclusions The association of the ZNF804A rs1344706 (A/C) polymorphism with NS of schizophrenia has not been reported so far though some studies have found the effect of this polymorphism on PANSS positive symptoms and PANSS total score. The finding of the association with NS can be explained by the fact that the NS heterogeneity was taken into account in the present study. Disclosure of Interest None Declared

[Polymorphic variants in the cluster of genes encoding trace amine receptors and cognitive functioning in patients with schizophrenia spectrum disorders and healthy controls]

The associations between cognitive functions and TSNAX genetic variations in patients with schizophrenia

Meta-analysis on Relationship Between TAAR6 Gene Polymorphisms and Schizophrenia

Associations between TCF4 Gene Polymorphism and Cognitive Functions in Schizophrenia Patients and Healthy Controls

A genome-wide association study of attention and executive function in patients with schizophrenia

[Genome-wide association study with memory measures as a quantitative trait locus for schizophrenia].

TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls

Brain-derived neurotrophic factor gene G196A polymorphisms and the cognitive function of schizophrenia: a case-control study

CACNA1C Gene Rs1006737 Polymorphism Affects Cognitive Performance in Chinese Han Schizophrenia

The association of GABRB2 SNPs with cognitive function in schizophrenia

Evidence for the contribution of HCN1 gene polymorphism (rs1501357) to working memory at both behavioral and neural levels in schizophrenia patients and healthy controls

Association Study of ZNF804A Gene Polymorphism Rs7597593 with Schizophrenia and Working Memory

The relationship between DNA methyctransferace 1 gene polymorphism and cognitive function in the first episode, drug-na?ve schizophrenia

Effects of Trans-ancestry Schizophrenia Risk Gene Polymorphisms on Working Memory and Underlying Brain Mechanisms

Evaluation of Association of Common Variants in HTR1A and HTR5A with Schizophrenia and Executive Function.

Association Of The Htr2c-759c/T Polymorphism And Antipsychotic-Induced Weight Gain: A Meta-Analysis

Association Of The Brain-Derived Neurotrophic Factor Gene G196a Rs6265 Polymorphisms And The Cognitive Function And Clinical Symptoms Of Schizophrenia

The Combined Effects of the 5‐ HTTLPR and HTR1A Rs6295 Polymorphisms Modulate Decision Making in Schizophrenia Patients

Relationship Between Brain-Derived Neurotrophic Factor Gene C270T Polymorphisms and the Psychotic Symptoms and Cognitive Functioning of Patients with Schizophrenia.

The Effects of CACNA1C Gene Polymorphism on Spatial Working Memory in Both Healthy Controls and Patients with Schizophrenia or Bipolar Disorder

The polymorphism ZNF804A rs1344706 is differentially associated with negative symptoms domains in schizophrenia